Aptitude Awarded a BARDA Contract Modification to Add Avian Flu Detection to the Metrix® Platform

Aptitude Awarded a BARDA Contract Modification to Add Avian Flu Detection to the Metrix® Platform

SANTA BARBARA, Calif., July 30, 2025 /PRNewswire/ -- Aptitude Medical Systems, Inc. (Aptitude) today announced it has been awarded a contract modification worth up to $8.25M from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for…

Aptitude Secures BARDA Contract Modification For Avian Flu

This funding will support the development of Avian H5 Influenza detection capabilities on the Metrix® platform, expanding upon its recent U.S. Food and Drug Administration (FDA) emergency use authorized COVID-19/Flu multiplex test.